Presentation and Outcomes With Clinically Apparent Interferon Beta Hepatotoxicity

Digestive Diseases and Sciences - United States
doi 10.1007/s10620-012-2553-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis
Neurology
2011English

Clinically Suspected Myocarditis With Pseudo-Infarct Presentation: The Role of Endomyocardial Biopsy

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Decreased Interferon Alpha/Beta Signature Associated With Human Lung Tumorigenesis

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2015English

T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis

Archives of Neurology
1999English

Review: Neutralizing Antibodies Against Interferon-Beta

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2008English

Apparent and True Resistant Hypertension: Definition, Prevalence and Outcomes

Journal of Human Hypertension
Internal Medicine
2014English

Effect on Cognition of Estroprogestins Combined With Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes From a Randomised Controlled Trial

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2016English

.BETA.-Interferon Therapy of Laryngeal Papilloma.

Practica Otologica
Otorhinolaryngology
1994English

Germline Polymorphism of Interferon-Lambda3 Is Clinically Associated With Progression of Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy